STAAR Surgical Company
STAA · NASDAQ
11/5/2025 | 9/26/2025 | 6/27/2025 | 3/28/2025 | |
|---|---|---|---|---|
| Market Cap | $1,250,380 | – | $837,878 | $877,830 |
| - Cash | $176,155 | – | $167,131 | $173,114 |
| + Debt | $39,117 | – | $40,520 | $36,678 |
| Enterprise Value | $1,113,342 | – | $711,267 | $741,394 |
| Revenue | – | $94,732 | $44,320 | $42,589 |
| % Growth | – | 113.7% | 4.1% | – |
| Gross Profit | – | $77,875 | $32,799 | $28,005 |
| % Margin | – | 82.2% | 74% | 65.8% |
| EBITDA | – | $26,442 | -$22,741 | -$32,400 |
| % Margin | – | 27.9% | -51.3% | -76.1% |
| Net Income | – | $8,884 | -$16,812 | -$54,211 |
| % Margin | – | 9.4% | -37.9% | -127.3% |
| EPS Diluted | – | 0.18 | -0.34 | -1.1 |
| % Growth | – | 152.9% | 69.1% | – |
| Operating Cash Flow | $2,667 | – | -$27,249 | -$5,734 |
| Capital Expenditures | -$883 | – | -$1,792 | -$1,468 |
| Free Cash Flow | $1,784 | – | -$29,041 | -$7,202 |